Logo image of CETX

CEMTREX INC (CETX) Stock Fundamental Analysis

USA - NASDAQ:CETX - US15130G8814 - Common Stock

5.11 USD
-0.18 (-3.4%)
Last: 10/3/2025, 3:41:15 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CETX. CETX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
In the past year CETX had a positive cash flow from operations.
CETX had negative earnings in each of the past 5 years.
In the past 5 years CETX always reported negative operating cash flow.
CETX Yearly Net Income VS EBIT VS OCF VS FCFCETX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of -53.90%, CETX is doing worse than 84.68% of the companies in the same industry.
With a Return On Equity value of -389.20%, CETX is not doing good in the industry: 95.16% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROIC N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
CETX Yearly ROA, ROE, ROICCETX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Gross Margin, with a value of 42.43%, CETX is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
CETX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CETX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
CETX Yearly Profit, Operating, Gross MarginsCETX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CETX has been reduced compared to 1 year ago.
CETX has less shares outstanding than it did 5 years ago.
CETX has a better debt/assets ratio than last year.
CETX Yearly Shares OutstandingCETX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
CETX Yearly Total Debt VS Total AssetsCETX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CETX has an Altman-Z score of -0.64. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
CETX has a worse Altman-Z score (-0.64) than 79.84% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that CETX has dependencies on debt financing.
CETX has a worse Debt to Equity ratio (1.48) than 91.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Altman-Z -0.64
ROIC/WACCN/A
WACC8.58%
CETX Yearly LT Debt VS Equity VS FCFCETX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

CETX has a Current Ratio of 1.21. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.21, CETX is not doing good in the industry: 85.48% of the companies in the same industry are doing better.
CETX has a Quick Ratio of 1.21. This is a bad value and indicates that CETX is not financially healthy enough and could expect problems in meeting its short term obligations.
CETX's Quick ratio of 0.95 is on the low side compared to the rest of the industry. CETX is outperformed by 79.03% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.95
CETX Yearly Current Assets VS Current LiabilitesCETX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CETX have decreased strongly by -564.41% in the last year.
CETX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.93%.
Measured over the past years, CETX shows a quite strong growth in Revenue. The Revenue has been growing by 11.21% on average per year.
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%

3.2 Future

Based on estimates for the next years, CETX will show a very strong growth in Earnings Per Share. The EPS will grow by 89.28% on average per year.
Based on estimates for the next years, CETX will show a quite strong growth in Revenue. The Revenue will grow by 15.00% on average per year.
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CETX Yearly Revenue VS EstimatesCETX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CETX Yearly EPS VS EstimatesCETX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2020 2021 2023 2024 2025 2026 0 100K -100K 200K -200K 300K

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CETX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 2.49 indicates a rather cheap valuation of CETX.
99.19% of the companies in the same industry are more expensive than CETX, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.29, CETX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.49
CETX Price Earnings VS Forward Price EarningsCETX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

CETX's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 70.38
CETX Per share dataCETX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600

4.3 Compensation for Growth

CETX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CETX's earnings are expected to grow with 89.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.28%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CEMTREX INC

NASDAQ:CETX (10/3/2025, 3:41:15 PM)

5.11

-0.18 (-3.4%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-12 2025-08-12
Earnings (Next)12-29 2025-12-29/amc
Inst Owners1.57%
Inst Owner Change501.78%
Ins Owners0%
Ins Owner Change0%
Market Cap29.02M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.49
P/S 0.39
P/FCF N/A
P/OCF 71.97
P/B 4.53
P/tB 10.77
EV/EBITDA 70.38
EPS(TTM)-610.99
EYN/A
EPS(NY)2.05
Fwd EY40.12%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)0.07
OCFY1.39%
SpS13
BVpS1.13
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.9%
ROE -389.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.43%
FCFM N/A
ROA(3y)-21.48%
ROA(5y)-19.29%
ROE(3y)-123.52%
ROE(5y)-88.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.38%
GM growth 5Y0.7%
F-Score5
Asset Turnover1.6
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF N/A
Debt/EBITDA 14.16
Cap/Depr 176.61%
Cap/Sales 3.12%
Interest Coverage N/A
Cash Conversion 60.18%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.95
Altman-Z -0.64
F-Score5
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)155.23%
Cap/Depr(5y)125.9%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-564.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%108.42%
EPS Next Y143.31%
EPS Next 2Y89.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.93%
Revenue growth 3Y15.76%
Revenue growth 5Y11.21%
Sales Q2Q%58.8%
Revenue Next Year15%
Revenue Next 2Y15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.5%
OCF growth 3YN/A
OCF growth 5YN/A